| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/31/2002 | EP1226132A1 Nonpeptide substituted benzothiazepines as vasopressin antagonists |
| 07/31/2002 | EP1226131A2 Isoxazolecarboxamide derivatives |
| 07/31/2002 | EP1226129A1 Methods and compositions utilizing quinazolinones |
| 07/31/2002 | EP1226128A1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 07/31/2002 | EP1226126A1 Pyrimidine derivatives |
| 07/31/2002 | EP1226124A1 Heterocyclically substituted benzoylguanidine, method for the production thereof, the use thereof as a medicament or means of diagnosis and a medicament containing the same |
| 07/31/2002 | EP1226122A1 Bicyclic vasopressin agonists |
| 07/31/2002 | EP1226121A1 Method of inhibiting neurotrophin-receptor binding |
| 07/31/2002 | EP1226120A2 Benz[f]indoles for use in the treatment of 5ht receptor related disorders |
| 07/31/2002 | EP1226119A2 Tyrosine kinase inhibitors |
| 07/31/2002 | EP1226115A1 Novel carbamates and ureas |
| 07/31/2002 | EP1226112A2 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 07/31/2002 | EP1226110A1 Bicyclic amino acids as pharmaceutical agents |
| 07/31/2002 | EP1226109A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 07/31/2002 | EP1226108A1 Diaryl-enynes |
| 07/31/2002 | EP1226104A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 07/31/2002 | EP1225956A1 Method and compositions for administering taxanes orally to human patients |
| 07/31/2002 | EP1225955A1 Aryl olefinic azacyclic, and aryl acetylenic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of nicotinic cholinergic receptors |
| 07/31/2002 | EP1225951A2 A dual adhesive transdermal drug delivery system |
| 07/31/2002 | EP1225923A1 Method of inactivating pathogens |
| 07/31/2002 | EP1225921A1 TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY i IN VIVO /i GENE DELIVERY |
| 07/31/2002 | EP1225919A1 Treatment of cancer |
| 07/31/2002 | EP1225917A2 Manufacture of polyglutamate-therapeutic agent conjugates |
| 07/31/2002 | EP1225913A1 Use of nitric oxide for the treatment of airway constriction |
| 07/31/2002 | EP1225909A2 Fibroblast growth factor-5 (fgf-5) is a tumor associated t-cell antigen |
| 07/31/2002 | EP1225905A1 The use of a positively charged carbohydrate polymer for the prevention of infection |
| 07/31/2002 | EP1225904A2 Combinations of lamivudine and entecavir for treatment of hepatitis b virus infection |
| 07/31/2002 | EP1225903A2 Aminoalkylenephosphonates for treatment of bone disorders |
| 07/31/2002 | EP1225902A1 Ciclesonide contained pharmaceutical composition for application to mucosa |
| 07/31/2002 | EP1225901A2 Uses and compositions for treating platelet-related disorders using anagrelide |
| 07/31/2002 | EP1225900A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/31/2002 | EP1225899A2 METHOD FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRIDAE /i VIRAL INFECTION USING NUCLEOSIDE ANALOGUES |
| 07/31/2002 | EP1225898A2 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum |
| 07/31/2002 | EP1225897A2 Composition for treatment of constipation and irritable bowel syndrome |
| 07/31/2002 | EP1225896A1 Isoxazole derivatives to be used as phosphodiesterase vii inhibitors |
| 07/31/2002 | EP1225895A1 Fab i inhibitors |
| 07/31/2002 | EP1225894A1 Fab i inhibitors |
| 07/31/2002 | EP1225893A2 A pharmaceutical composition containing lycopene for stabilizsing atherosclerotic plaques |
| 07/31/2002 | EP1225892A2 Hypoestoxides, derivatives and agonists thereof for use as antiparasitic agents |
| 07/31/2002 | EP1225890A1 Rivastigmine for the treatment of ocular disorders |
| 07/31/2002 | EP1225888A2 Sustained-release formulations for treating cns-mediated disorders |
| 07/31/2002 | EP1225887A2 Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 07/31/2002 | EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 07/31/2002 | EP1225885A2 A therapeutic mixture of hmg-coa reductase inhibitors |
| 07/31/2002 | EP1225884A1 Method for administering a phosphodiesterase 4 inhibitor |
| 07/31/2002 | EP1225883A1 Anti-ischemic compounds |
| 07/31/2002 | EP1225882A1 Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines |
| 07/31/2002 | EP1225881A1 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
| 07/31/2002 | EP1225880A2 Use of a hmg-coa reductase inhibitor for treating amyloid beta precursor disorders |
| 07/31/2002 | EP1225879A2 Ophthalmic formulation of dopamine antagonists |
| 07/31/2002 | EP1225878A1 Treatment of emphysema using rar selective retinold agonists |
| 07/31/2002 | EP1225877A2 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 07/31/2002 | EP1225875A2 Apparatus and process for preparing crystalline particles |
| 07/31/2002 | EP1225874A1 Antiviral compositions |
| 07/31/2002 | EP1225872A1 New and improved formulation for paclitaxel |
| 07/31/2002 | EP1225866A2 Method and compositions for treating pulmonary diseases |
| 07/31/2002 | EP1225846A2 Bioprosthetic heart valves |
| 07/31/2002 | EP1225814A1 Fibrous-liponutritional complexes and compositions containing them |
| 07/31/2002 | EP1225813A1 Cholesterol reducing stanol compositions, preparation and method of use |
| 07/31/2002 | EP1225812A2 Cholesterol reducing sterol compositions, preparation and method of use |
| 07/31/2002 | EP1225810A1 Method for treatment of chronic venous insufficiencies using an extract of red vine leaves |
| 07/31/2002 | EP1137414A4 Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis |
| 07/31/2002 | EP1102783A4 Aminooxy-modified nucleosidic compounds and oligomeric compounds prepared therefrom |
| 07/31/2002 | EP1042310B1 Method for the preparation of citalopram |
| 07/31/2002 | EP1035846B1 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals |
| 07/31/2002 | EP1009750B1 Novel (alpha-aminophosphino) peptide derivatives, method for making same and therapeutic applications thereof |
| 07/31/2002 | EP0980377B1 Anti-viral pyrimidine nucleoside analogues |
| 07/31/2002 | EP0958290B1 1,4-dihydropyridin derivatives and their use in therapy |
| 07/31/2002 | EP0920630B1 Prion binding proteins and uses thereof |
| 07/31/2002 | EP0914115A4 Methods of providing neuroprotection |
| 07/31/2002 | EP0880500B1 Esters of 3-hydroxy-piperidinemethanol derivatives |
| 07/31/2002 | EP0854867B1 Tetrahydroquinolines as nmda antagonists |
| 07/31/2002 | EP0850244B1 Toxoplasma gondii glycoconjugates |
| 07/31/2002 | EP0833837B1 Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
| 07/31/2002 | EP0825848B1 Translucent collagen formulations |
| 07/31/2002 | EP0824534B1 9,10 disubstituted camptothecin derivatives with antitumor activity |
| 07/31/2002 | EP0824356B1 Pharmaceutical compositions for the treatment of alcohol addiction |
| 07/31/2002 | EP0817969B1 Inhibition of tau-tau-association |
| 07/31/2002 | EP0810883B1 Conjugate comprising dtpa and albumin for individual medicament dosing |
| 07/31/2002 | EP0799047B1 Viscous liquid conditioning topical germicides |
| 07/31/2002 | EP0764152B1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
| 07/31/2002 | EP0760650B1 Antimicrobial oil-in-water emulsions |
| 07/31/2002 | EP0755930B1 Benzoxazepine derivatives, salts thereof, and drugs containing the same |
| 07/31/2002 | EP0755398B1 Process for the resolution of etodolac using glucamine derivatives |
| 07/31/2002 | EP0735871B1 Pharmaceutical compositions containing ceftriaxone and penems |
| 07/31/2002 | EP0731699B1 Method of reducing body fat in animals by the administration of conjugated linoleic acid |
| 07/31/2002 | EP0719267B1 Second messenger cell signaling inhibitors |
| 07/31/2002 | EP0698109B1 Gene transfer into pancreatic epithelial cells |
| 07/31/2002 | EP0583356B1 A method for treating infectious respiratory diseases |
| 07/31/2002 | EP0527801B1 Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
| 07/31/2002 | CN1361865A Catalytic anti-factor VIII allo-antibodies |
| 07/31/2002 | CN1361789A Rapid dehydration of proteins |
| 07/31/2002 | CN1361785A Titanium derived compounds, preparation and use thereof |
| 07/31/2002 | CN1361783A Thiazoloderivatives and pharmaceutical compositions containing them |
| 07/31/2002 | CN1361782A Substituted imidazothiazoles as antidepressant agents |
| 07/31/2002 | CN1361781A Oxazinocarbazoles for the treatment of CNS diseases |
| 07/31/2002 | CN1361780A Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 07/31/2002 | CN1361779A New compounds |
| 07/31/2002 | CN1361776A Novel fluorinated imidazoline Benzodioxane, preparation and therapeutic uses thereof |
| 07/31/2002 | CN1361775A Novel diphenyl-piperidine derivate |